With over 35M adults living with chronic kidney disease #CKD, and another large percentage of the population unaware they have it, addressing #kidneydisease is not only important to our health, it is seen as one of the largest emerging frontiers with its multibillion dollar market potential. With #kidney disease, the body has trouble removing surplus potassium from the #blood. This causes potassium levels to rise, which can lead to problems with other major organs including the heart. In this clip of Tech Talks with Holly Scott, David Kuraguntla, CEO of Alio, explains that we "Don't think about kidney enough" and how Alio's #smartpatch is working to help manage this patient population with more actionable information, while empowering the patient with more control and peace of mind. Link to the full discussion in the comments.
The Mullings Group’s Post
More Relevant Posts
-
Join us this Wednesday at 8am CT / 9am ET for a virtual webinar, Simplifying the Complexity of Diagnosing Breast Cancer: A Fireside Chat with Seno Medical featuring Frost & Sullivan hosted by Dragonfly - A TMG Company. Moderated by Nicole Ager, Thomas Umbel, CEO of Seno Medical and Sudhakar Mishra, Sr. Director for Growth Advisory within Healthcare & Lifesciences for Frost & Sullivan will dive into the current standard of care, diagnostic imaging, bringing new technology to the market, and more. Link to register: https://lnkd.in/eyTiVy8Y
-
-
The Mullings Group team is onsite in Orlando, FL this week attending #SRS2024, where they will gain further insight into the latest innovation and advancement within the #surgical #robotics space. Dragonfly - A TMG Company will be there on the floor conducting interviews in our full studio in the middle of the event. We are looking forward to seeing you there. Joe Mullings Nicole Ager Tori Gould Wesley Kennedy-Sita
-
-
Tune in for our upcoming fireside chat webinar on July 10th at 8AM CT/9AM ET hosted by Dragonfly - A TMG Company with Seno Medical & Frost & Sullivan. Seno CEO, Thomas Umbel says: “I am looking forward to sharing how our FDA/PMA approved Imagio® imaging technology along with our SenoGram® decision support AI tool will impact the current carepath for Breast Cancer diagnosis going forward.” Tom will be joined by Charlie Whelan & Sudhakar Mishra for the discussion moderated by Nicole Ager. Link to register: https://lnkd.in/eyTiVy8Y
-
-
Exciting strides in post-prostatectomy recovery. Levee Medical, Inc. has announced a $10M Series B round of financing to accelerate the development of its groundbreaking Voro Urologic Scaffold. This #innovative technology aims to revolutionize post-prostatectomy care, offering new hope for improved recovery outcomes. With a strong focus on patient well-being, Levee Medical is poised to redefine standards in urologic #healthcare. Read more about the funding and the potential impact of Voro Urologic Scaffold in enhancing patient recovery journeys here: https://lnkd.in/eSkgSG9Z
-
The Mullings Group Companies is west coast bound for the MedTech Innovator Summit in Mountain View, CA. Dragonfly - A TMG Company is proud to be the Official Media Partner for the event. In partnership with Paul Grand and the MTI team, we will be capturing the stories and full experience of MedTech Innovator. Holly Scott & Nicole Ager will be leading a breakout session covering Attention & Awareness as you build a buzz around your company to attract talent, investment, and value. See you in Cali!
-
-
It has already been a year since we won the Surgical Robotics Technology Industry Leadership Award for the medical device industry. We have been fortunate to be nominated once again for the Industry Leadership Award and boy would we like to two-peat! “If you feel so compelled to support me again for the Industry Leadership Award, I ask that you cast your vote to push me to the top one more time.” - Joe Mullings We are proud and privileged to bring you breaking news, new technologies, and analytics on where the market is going for you as you build your careers and companies in the fantastic surgical robotics space. Thanks again for your support! Link to vote (voting closes June 11th): https://lnkd.in/eJU6WtWz
-
-
We are proud and privileged to have our Chairman & CEO, Joe Mullings appointed to the MedTechVets Board of Directors. We look forward to the continued partnership with MedTechVets, an incredible organization dedicated to supporting veterans transitioning into careers within the MedTech sector. Steve Mapa Michael Minogue
-
-
Introducing technology into an existing healthcare market can be daunting. How do you position your innovation such that the market sees it as solving their greatest challenges? In your course to commercialize, how do you choose the right regulatory and go-to-market strategies? Dragonfly - A TMG Company is looking forward to hosting an upcoming fireside chat with Seno Medical and Frost & Sullivan: “Simplifying the Complexity of Diagnosing Breast Cancer”. Join Thomas Umbel, Charlie Whelan, Sudhakar Mishra for a discussion covering the breast cancer landscape and the introduction of a new imaging modality, moderated by Nicole Ager. Link to register: https://lnkd.in/eyTiVy8Y
-
-
StrokeDx announced the closing of $5M in Series Seed Prime funding today led by DigiTx Partners with participation by Freeflow Ventures and other existing investors. StrokeDx is developing next-generation stroke detection and monitoring solutions. This funding will enable StrokeDx to scale their solution to empower physicians and their patients with this tool for point-of-care cerebrovascular monitoring. Last year, MedTech Innovator named StrokeDx as the 2023 Global Competition Winner at The MedTech Conference, powered by AdvaMed. Read more here: https://lnkd.in/ewr7EFRb Paul Grand Alex Ballatori Shane Shahrestani, MD, PhD #stroke #diagnostics #medtech #innovation
StrokeDx Raises Oversubscribed $5 Million Seed Prime Round to Advance Next-Generation Stroke Technology - TMG Pulse
https://tmgpulse.com
Full discussion here: https://youtu.be/b4_ISeELnF0?si=6y2uSO-r4M5nippn